Electrospun Matrices Using Natural Synthetic Polymer Blends
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic matrices used for tissue engineering often elicit an adverse immune response and are limited in supply, while decellularized matrices, although promising, are not readily available in sufficient quantities with the desired composition and ultrastructure similar to native tissue.
Innovation Solution
Electrospun matrices are created using a combination of natural biological materials like collagen and synthetic polymers, such as PLGA, which can be crosslinked for increased strength and stability, allowing for controlled delivery of therapeutic agents and monitoring, and are designed to mimic the mechanics and structure of native tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If synthetic matrices are used for tissue engineering, then structural support and mechanical strength are provided, but adverse immune response is elicited
Solution Approach 1:
The patent uses composite materials combining synthetic polymers (PLGA, PCL) with natural biological materials (collagen, elastin, gelatin) to create electrospun matrices. This composite approach provides the mechanical strength of synthetic materials while incorporating biocompatible natural components that reduce immune response. The synthetic-natural polymer blend allows simultaneous achievement of structural integrity and biocompatibility.
Solution Approach 2:
The patent modifies material parameters by controlling the molecular weight, ratio, and composition of polymer blends during electrospinning. By adjusting these parameters, the matrix achieves optimal balance between mechanical properties and biocompatibility. The crosslinking degree and fiber diameter are also tuned to achieve desired strength while maintaining cell-friendly characteristics.
2Object-affected harmful factors
If decellularized matrices are used as scaffolds, then natural composition and biocompatibility are achieved, but supply is limited
Solution Approach 1:
The patent creates synthetic-electrospun matrices that copy and replicate the composition, ultrastructure, and biomechanical properties of native decellularized matrices. By using natural polymers like collagen and elastin in electrospun configurations, the invention reproduces the beneficial features of decellularized scaffolds (biocompatibility, natural composition) without being constrained by their limited availability from donor tissues.
Solution Approach 2:
The patent controls fiber diameter, porosity, and material composition parameters during electrospinning to match the ultrastructural characteristics of native tissue matrices. This allows replication of the natural extracellular matrix architecture that supports cell attachment and growth, achieving biocompatibility comparable to decellularized matrices while enabling scalable production.
3Object-affected harmful factors
If natural biological materials are used in electrospun matrices, then biocompatibility is improved, but mechanical strength is reduced
Solution Approach 1:
The patent employs composite material systems where natural polymers (collagen, elastin) are blended with synthetic polymers (PLGA, PCL) in specific ratios. The synthetic component provides mechanical reinforcement while the natural component ensures biocompatibility. This composite strategy allows the matrix to simultaneously achieve adequate mechanical strength for tissue engineering and high biocompatibility for cell attachment and growth.
Solution Approach 2:
The patent may incorporate different material compositions in different regions or layers of the electrospun matrix. Areas requiring higher mechanical strength can have increased synthetic polymer content, while regions requiring enhanced biocompatibility can have higher natural polymer content. This spatial variation in material quality allows optimization of both properties in different functional zones.
4Strength
If high molecular weight polymers are used in electrospun matrices, then mechanical strength is increased, but ease of manufacture is reduced
Solution Approach 1:
The patent carefully selects and adjusts polymer molecular weight parameters to achieve an optimal balance. High molecular weight polymers provide mechanical strength, but the patent modifies other parameters (polymer concentration in solution, solvent composition, electrospinning voltage, humidity control) to ensure that high MW polymers remain processable. This multi-parameter optimization allows use of high MW polymers for strength while maintaining ease of manufacture through controlled electrospinning conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The electrospun matrices provide biocompatible scaffolds that support cellular attachment and growth, achieving mechanical properties similar to native tissues, such as vascular scaffolds that can withstand physiological stresses, and enable controlled release of therapeutic agents, enhancing tissue engineering applications.
Implementation Method 1
Electromagnetic fields created by high voltage sources during electrospinning cause biomaterials in a solvent to elongate and splay into ever-smaller fibers
Implementation Method 2
As the fibers become smaller, evaporation of the solvent occurs more quickly and fiber sizes of nanometer diameter can be achieved
Data Source
AI summary
The invention is directed to compositions and methods for preparing electrospun matrices comprising at least one natural biological material component and at least one synthetic polymer material. The natural component makes the matrices highly biocompatible while the molecular weight polymer component can impart additional strength mechanical strength to the scaffold and/or improve ease of manufacture by increasing viscosity and spinning characteristics of the solution during electrospining.